Cell–cell interactions promote juxtacrine signals in specific subcellular domains, which are difficult to capture in the complexity of the nervous system. For example, contact between axons and Schwann cells triggers signals required for radial sorting and myelination. Failure in this interaction causes dysmyelination and axonal degeneration. Despite its importance, few molecules at the axo-glial surface are known. To identify novel molecules in axo-glial interactions, we modified the ‘pseudopodia’ sub-fractionation system and isolated the projections that glia extend when they receive juxtacrine signals from axons. By proteomics we identified the signalling networks present at the glial-leading edge, and novel proteins, including members of the Prohibitin family. Glial-specific deletion of Prohibitin-2 in mice impairs axo-glial interactions and myelination. We thus validate a novel method to model morphogenesis and juxtacrine signalling, provide insights into the molecular organization of the axo-glial contact, and identify a novel class of molecules in myelination.
Myelin is required for fast conduction of neural impulses, preserves axons, and is implicated in demyelinating and neurodegenerative diseases1. The core of this function lies at the polarized surface of contact between myelin-forming glia and axons. Because this surface lies beneath a series of concentric inward wraps of myelin, it is inaccessible to biochemical isolation, making the studies of this crucial nervous system apposition arduous. Indeed, only few molecules have been identified in this location. More generally, compartmentalization of signalling events is crucial for glia, neurons and other polarized cells, and cell–cell interactions are at the basis of morphogenesis and are required for the function of all tissues. Only a few tools are available to study these events in specific subcellular domains.
Insights into the spatial organization of signalling networks have been obtained using the pseudopod subcellular fractionation system, in cells responding to chemotactic (soluble) or haptotactic (extracellular matrix) stimuli2,3. In this system2, cells are placed in a chamber with a microporous membrane, and extend pseudopodia in response to stimuli in the bottom chamber. Pseudopods can be imaged and isolated from the cell body, which remains on the top chamber due to the size of the nucleus. However, this method has not yet been applied to juxtacrine signalling.
Here we sought to adapt the pseudopod system to the study of cell–cell interactions in the nervous system. Our goal is to identify signalling events, molecular networks and novel molecules specifically at the axo-glia interface. Schwann cells (SC) make myelin in peripheral nerves, in response to contact with axons and the basal lamina (reviewed in ref. 4), making them excellent instruments to test if pseudopod sub-fractionation can model juxtacrine signalling. To ask whether this system was suitable to study signals between axons and glia, we replaced soluble stimuli with neuronal cell membranes, to mimic cell–cell contact, and isolated the cytoplasmic processes (pseudopods) that Schwann cells extend to contact axon membranes. By proteomic analysis we identified proteins that partitioned in pseudopods uniquely after axonal signals, including novel proteins and proteins known to localize at the Schwan cell–axon interface in vivo. We also identified the major signalling networks induced by Schwann cell–axonal contact, and a novel protein family, Prohibitins, which we show is required for appropriate axo-glial interactions in vivo. This validation confirms that we were able to successfully model complex morphogenetic cell–cell interactions. This novel method opens the possibility to map subcellular events that occur during the interactions between neurons and other glial cells, or between any cells.
SC extend pseudopods in response to chemotactic stimuli
Several cell types such as fibroblasts (NIH3T3) in vitro respond to gradients of certain chemoattractants (for example, lysophosphatic-lysophosphatidic acid (LPA), but not insulin) by directional cell migration2. The initial step is the extension of a polarized protrusion (‘pseudopod’) that can be isolated by placing the cells on top of a Boyden chamber with microporous filters (3-μm pores) and the chemoattractant on the bottom2 (Fig. 1a). Cell bodies and pseudopods can then be separated.
To determine if primary Schwann cells respond like other cells, we compared their response (Fig. 1f–j) to that of NIH3T3 cells (Fig. 1a–e) to LPA, or to a combination of fetal calf serum, forskolin and growth factors. By staining the top or the bottom of the membrane with phalloidin and DAPI, and imaging with confocal microscopy focused sequentially above and below the membrane, we showed that both primary Schwann cells and NIH3T3 cells extended pseudopods in response to the chemoattractants, but not to DMEM alone (Fig. 1b,g). As expected, nuclei were detected solely on the upper surface, confirming that only pseudopods protruded through the small pores. Proteins from the cell bodies or pseudopods can be solubilized independently and quantified or analysed. Polarization was confirmed biochemically by showing that nuclear histones were present mostly in the cell body fraction (Fig. 1d,i). Protein quantification after 2 h of exposure to LPA or serum and growth factors confirmed that significantly more proteins were extracted from the pseudopod fraction in the presence of the chemoattractants (Fig. 1c,h). We next asked if the kinetics of pseudopod growth were similar in the two cell types. The extension of pseudopods in both Schwan cells and NIH3T3 cells was detected as early as 30 min after exposure to chemoattractants, and pseudopod growth reached a plateau after 2 h (Fig. 1e,j), similar to previous reports. Removal of the chemoattractant reversed the polarization of the Schwann cells and induced pseudopod retraction (Supplementary Fig. 1), confirming that the formation of pseudopods is an active and reversible process2.
Previous studies showed that the molecular machinery required for the extension of pseudopods resembles that required for extension of a leading edge in polarizing cells at the beginning of migration2, including regulators of the actin cytoskeleton. We thus wished to confirm that Schwann cell pseudopods contained regulators of actin polymerization, and molecules required for formation of Schwann cell protrusions. For example, Rac1, and Fak are required in vivo for Schwann cells to form polarized lamellipodia around axons and to begin myelination5,6 and p-Akt is associated with the onset of myelination7; in contrast p-Erk is not required for initial wrapping, but for addition of subsequent myelin layers8,9. Indeed we found that Rac1, p-Fak and p-Akt, but not p-Erk, were enriched in pseudopods (Fig. 1i).
Cells can polarize and migrate also towards haptotactic stimuli, like polymerized extracellular matrix, and this can also be mimicked in the pseudopod system3. Accordingly, Schwann cells extended pseudopods in response to Laminin polymerized on the lower membrane and the Laminin receptors β-Dystroglycan redistributed to these pseudopods (Supplementary Fig. 2).
These results demonstrate that Schwann cells respond to soluble or haptotactic physiological stimuli by extending polarized pseudopods, which contain the appropriate molecular machinery.
SC extend pseudopods in response to neuronal membranes
It is established that contact between Schwann cells and axons is strictly required for induction of myelination. Neuronal membrane preparations have been used as a model for axonal contact itself10,11. Thus, we asked if Schwann cells could extend polarized pseudopods in response to juxtacrine signals from neuronal membranes, and if the Schwann cell response to neuronal membranes was specific and unique.
We prepared neuronal membranes from isolated dorsal root ganglia (DRG) neurons, and confirmed that they were biologically active by showing that they induced Akt phosphorylation in Schwann cells (Fig. 2a). The key juxtacrine signal on axons is Neuregulin 1-type III, which is required for Schwann cell myelination12,13, while soluble Neuregulin 1-type 1 cannot promote myelination unless it is presented at high concentration or after injury14,15. Consistent with these published data, when we placed soluble Neuregulin 1-type I on the bottom chamber, Schwann cells failed to extend pseudopods (Fig. 2b,d). Similarly, when we plated DRG neurons on the bottom chamber, at a distance (0.2 mm) from the Schwann cells that precludes contact, the physical separation prevented formation of pseudopods (Fig. 2b,e). In contrast, when we filled the bottom chamber with a suspension of neuronal membranes, such that integral proteins in neuronal membranes could contact the Schwann cells, Schwann cells responded by making polarized protrusions (Fig. 2b,f). These data suggest that the formation of Schwann cell protrusions requires neuronal contact, like myelination itself, and they are consistent with the notion that soluble signals from neurons are not sufficient to induce myelination12. Three-dimensional (3D) reconstruction and volume rendering showed that most cells responded by extending pseudopods, and that pseudopods were polarized (that is, extended only through the pores towards the neuronal membranes; Supplementary Fig. 3, Supplementary Movie 1). Importantly, membrane suspensions prepared from non-neuronal cells did not induce the extension of Schwann cell protrusions (Supplementary Fig. 4). Thus, only the direct contact between Schwann cells and neuronal membranes promotes the extension of Schwann cell pseudopods, supporting that they may represent a model of the first polarization events leading to myelination.
As before, we confirmed that molecules required for extension of membrane protrusions, migration and myelination such as Rac1, p-Fak and p-Akt partitioned in the pseudopods induced by neuronal membranes, while nuclear histones partitioned preferentially in the cell bodies (Fig. 2g). We next asked whether Schwann cell pseudopods contained molecules located at the glial surface that faces axons. Remarkably, only few molecules at this important site are known. Among them, N-cadherin is polarized immediately to sites of axo-glial contact, where it recruits Par3; Necl4 localizes at the axo-glial surface in mature fibers, and the receptor ErbB2/3 should localize near axons to interact with axonal Neuregulins16,17,18,19. Notably, only N-cadherin, that mediates the first axonal contact, was clearly enriched in pseudopods, whereas ErbB receptors and Necls were present in both fractions, and Par3 was only detectable in cell bodies. This suggests that full polarization requires either >2 h after axonal contact or a second polarizing event, likely from the basal lamina. Alternatively, it is possible that post-translational modifications that activate these molecules occur preferentially in pseudopods. For example, it will be interesting in the future to determine whether ErbB2 and ErbB3 phosphorylation occurs mainly in pseudopods. Finally, pseudopods did not contain the axonal specific molecules Caspr and Contactin-1 (Supplementary Fig. 5), indicating that neuronal membranes did not contaminate the pseudopod proteome. These results demonstrate that Schwann cells respond to juxtacrine signals in neuronal membranes by producing polarized pseudopodia that mimic the early cellular protrusions of intact neuro-glial systems. Thus the pseudopod system can model specific cell–cell interactions.
Pseudopods induced by neurons contain a specific proteome
Having shown that Schwann cells respond specifically to juxtracrine neuronal signalling by producing appropriate polarized protrusions, we next determined the proteome of the pseudopods and compared it to that of cell bodies. We analysed equal amounts of pseudopod and cell body lysates (Fig. 3a, Supplementary Fig. 5a) and quantified the relative abundance of a given protein in the lysates in the induced (neuronal membranes) versus non-induced (DMEM) condition, by stable isotope labelling (SILAC), coupled with liquid chromatography–tandem mass spectrometry (LC–MS/MS). We reliably identified 714 proteins, 605 of which were present in neuronally induced pseudopods (Supplementary Data 1). Of these, 176 proteins were enriched in pseudopods (as compared to cell bodies: Ps/CB ratio>1.25, Fig. 3c). Among these, 95 proteins were also relatively increased in pseudopods after induction with neuronal membranes (as compared to DMEM: Ps induced by neurons/Ps non induced >1, Fig. 3b,d and Supplementary Data 2).
Formation of polarized protrusions in any cells requires the cytoskeleton. Accordingly, the largest group of proteins enriched in pseudopods and increased during neuronal contact was associated with the cytoskeleton (19%; Supplementary Data 2). However, we wished to ask whether neuronal membranes also induced a specific response in Schwann cells, given the unique molecular and geometrical relationships between the two cells. To distinguish between molecules induced by any chemotactic, promigratory stimulus and molecules induced specifically by neuronal membranes, we compared the proteome of Schwann cell pseudopods generated by neuronal membranes (Supplementary Data 1) with that generated in response to fetal calf serum plus growth factors (Supplementary Data 3). Notably, we identified only 23 proteins that were enriched by both stimuli, representing 24% of the proteins enriched in pseudopods by neuronal membranes (Fig. 3b, indicated in grey). The remaining 76% of the proteins were enriched exclusively by neuronal membranes (Fig. 3b, indicated in black, Supplementary Data 4). This suggests that signalling by neuronal membranes elicits the redistribution not only of proteins required for the formation of cellular protrusions, it also induces a larger and unique set of specific proteins.
We next asked whether the proteome that varied in response to neuronal membranes included novel proteins, and proteins already known to function in myelination, both were present. Among the 95 proteins that increased in response to interaction with neuronal membranes, we found Integrin β1, Necl4 and cAMP-dependent protein kinase type I—α regulatory subunit—that are required for Schwann cell–axon interactions in vivo20,21,22, whereas N-CAM mediates homotypic axon-Schwann cell interactions in vitro23. Other proteins are implicated in oligodendrocyte myelination and integrity in vivo, such as Galectin 324 and Niemann–Pick C1 (NP–C)25.
Overall, these results reveal that contact with neuronal membranes induces significant Schwann cell polarization. Remarkably, 76% of the proteins identified were uniquely redistributed after induction with neuronal membranes, but not after exposure to serum and growth factors, indicating that juxtacrine signals from neurons induce a specific set of proteins to redistribute in Schwann cells. Finally, the presence of molecules known to be important in axo-glial interactions indicates that our method is successful in the identification of proteins relevant to axo-glial contact and myelination.
Novel proteins and signalling networks in pseudopods
We next characterized the interaction network of polarized protrusions in Schwann cells and searched for novel proteins. We used Ingenuity Pathways Analysis to find canonical pathways that were involved, and to represent the protein-protein interactome (based on the Ingenuity Knowledge Base). Strikingly, many of the proteins that were polarized by axonal contact were interconnected in networks (Fig. 3b) suggesting that they are functionally related. The pathways most enriched in the pseudopods included both novel signalling networks and proteins already shown to be important. For example, Rho GTPases and Rho GDI, Tec Kinase and G Beta Gamma signalling (Fig. 3e, Supplementary Data 5) were the pathways most represented. β1 integrin and RhoC were constituents of these three pathways (Supplementary Data 5), suggesting a potentially important role for RhoC, given that β1 integrin and other small Rho GTPases and effectors (Rac1, Cdc42, Rock and Mlck) are required for axo-glial interactions6,21,26,27,28. Similarly, 9 out of the 10 most abundant pathways shared the heterotrimeric G proteins encoded by Gnb1, Gnb2, Gnb2L1, Gnao1 and Gnai2 (Supplementary Data 5), which expand the notion that G-protein signalling is a major contributor of radial sorting and myelination29.
We also noted that three out of the seven pseudopod proteins that were most induced by neuronal membranes as compared to DMEM (above 5 × fold, Fig. 3d) were secreted (that is, Secreted frizzled-related protein 1, a Wnt inhibitor; Htra1 and Tissue plasminogen activator (tPA) encoded by Plat). Interestingly, among these secreted molecules Wnt signalling is important during Schwann cell development30, and tPA is important during axonal regeneration31.
We also identified three proteins with a Prohibitin homology domain: Prohibitin-1, Prohibitin-2 and Erlin-1. This domain is found in a small subset of proteins in higher eukaryotes: Prohibitins, Erlins, Stomatins, Flotillins and Podocin (http://smart.embl.de/). Originally described and characterized as mitochondrial inner-membrane proteins32, Prohibitins have pleiotropic effects. They localize at the plasma membrane, where they interact with various receptors and activate the Ras–Raf signalling pathway33; in the cytoplasm, where they interact with mTOR34; or in the nucleus, where they are Akt substrates35 and repress transcription of Yy136. As all of these latter molecules are involved in myelination, we asked if Prohibitins engaged in axo-glial interactions.
Subcellular localization of prohibitins
Among the 95 proteins that were polarized and enriched in protrusions by neuronal membranes, 4 were predicted to be secreted, 16 transmembrane or membrane associated, 53 cytoplasmic, 19 in organelles (mitochondrial, ER, peroxisome and lysosomes) and 3 nuclear (Supplementary Data 2). Because 12% of these proteins were identified as mitochondrial, including Prohibitins, we asked whether mitochondria were present and enriched in pseudopods. We stimulated Schwann cells with neuronal membranes and stained them with phalloidin and mitotracker. We detected some mitochondria in the pseudopods, although the majority of mitochondria were found in cell bodies (Fig. 4a).
To characterize the localization of Prohibitins in Schwann cells, we first confirmed that Prohibitin-1 and -2, were present in pseudopods by infrared-based western blot analysis. Both proteins were present in pseudopods, and we could confirm that Prohibitin-2, was more abundant in pseudopods (2.8 Ps/CB ratio by SILAC mass spectrometry; Fig. 4b). While we could not detect a significant enrichment of Prohibitin-1, this is probably due to the poor quantitative sensitivity of western blot in the range of PhB1 enrichment (1.3 Ps/CB ratio by SILAC mass spectrometry).
We next asked whether we could detect Prohibitins in Schwann cell mitochondria and pseudopods, and we focused on the more polarized Prohibitin-2. By immunohistochemistry, the majority of Prohibitin-2 in Schwann cells cultured on poly-L-lysine co-localized with mitochondria (Fig. 4c). When we exposed Schwann cells to neuronal membranes in the Boyden chamber, Prohibitin-2 was readily detected in pseudopods, where it still colocalized with mitochondria, but also with the membrane protein β1 integrin in small lamellipodia (Fig. 4d).
Because Prohibitins are exposed to the external membrane of activated T cells37 we asked whether Prohibitins were also present at the external surface of Schwann cells. We biotinylated Schwann cells, and followed by either streptavidin pull-down and blotting with anti-Prohibitin-2 antibodies (Fig. 4e) or by Prohibitin-2 immunoprecipitation and blotting with Streptavidin-HRP (Fig. 4f). In both cases, Prohibitin-2 was found together with biotinylated proteins of Schwann cell plasma membrane. β1 integrin, a membrane protein, behaved like Prohibitin-2 (Fig. 4e), whereas the exclusively mitochondrial protein Pdha-1 could not be pulled-down by biotin–streptavidin (Fig. 4e). These data indicate that a fraction of Prohibitin-2 is either present on the Schwann cell surface, or interacts with proteins present on Schwann cell surface. However, this fraction must be small, because by immunocytochemistry the majority of Prohibitin-2 was detected in mitochondria in cultured Schwann cells (Fig. 4a). Thus, Prohibitins localize to pseudopods in Schwann cells, where they are present both in mitochondria and at the cell membrane.
Prohibitins are necessary for myelination in vitro
To determine the function of Prohibitins in Schwann cells, we first asked if silencing Prohibitins would affect the extension of Schwann cell pseudopods and their interaction with neurons. Schwann cells were infected with viruses expressing different shRNAs for either Phb1 or Phb2. All shRNAs reduced expression of Phb1 or Phb2, as shown by western blot (Fig. 5a,b). Schwann cells silenced for Prohibitins still extended pseudopods in response to neuronal membranes (Fig. 5c). However, when silenced Schwann cells were seeded on dorsal root ganglia neurons, fewer of them attached to neurons (Fig. 5d–f) and those that were attached frequently had an aberrant morphology on axons (Fig. 5g). This may suggest that silencing of Prohibitins in Schwann cells impairs early interactions with axons.
Because Prohibitin silencing reduced the number of Schwann cells that attached to axons, we asked whether this was due to changes in apoptosis or proliferation. Prohibitins were originally described as inhibitors of cell proliferation, hence their name38, and regulators of apoptosis (reviewed in ref. 39). Silencing of Prohibitins did not affect Schwann cell proliferation, but slightly increased apoptosis early after plating on axons (1 day, Supplementary Fig. 6c,d), and more significantly when Schwann cells were cultured alone (Supplementary Fig. 6a,b). After 3 days of co-culturing with axons, Schwann cell apoptosis returned to normal levels, even if the number of Schwann cells remained decreased by about 15% (Supplementary Fig. 6 e–h). This suggests that axons provide survival signals that compensate for Prohibitin silencing.
When switched to a myelinating condition by adding ascorbic acid to the cultures, myelination of axons was severely impaired after silencing of either Prohibitin-1 or -2 (Fig. 6a-c). To ask whether this was due to the reduced number of Schwann cells (15% less in this condition, Supplementary Fig. 6h) we seeded three times the amount of silenced Schwann cells on DRG neurons. As shown in Fig. 6d and e, this rescued the difference in Schwann cell number, but not myelination, indicating that the reduced number of myelin segments is not due simply to a reduction in the number of Schwann cells. Taken together, these data show that Prohibitins may be required for Schwann cell–axon interactions and that they are required for myelination in vitro.
Prohibitin-2 is required for radial sorting and myelination in vivo
Prohibitin-2 was highly expressed in sciatic nerves during active myelination (P1-P15, Fig. 7a), and its expression was shown to be modulated after nerve injury40. By immunohistochemistry of sciatic nerves, Prohibitin-2 appeared to localize in Schwann cells and axons, and not to be restricted to mitochondria (Fig. 7). At Postnatal day (P)1, the beginning of myelination, Prohibitin-2 staining was in Schwann cells near axons (Fig. 7b). We generated mice in which Prohibitin-2 was deleted specifically in Schwann cells. Constitutive ablation of Phb2 is lethal in utero before embryonic day 9.5 (E9.5)41. Mice with the Phb2 gene flanked by LoxP sites42 were crossed with P0-Cre mice43 that drive Cre expression in Schwann cells starting at E13.521. In wild-type (WT) nerves Prohibitin-2 was present in Schwann cells and axons, but in mutant nerves it was only in axons at P1 and P20 (Fig. 7c,d), confirming early and Schwann cell-specific Cre-mediated recombination. Strikingly, ablation of Prohibitin-2 caused a severe motor deficit and muscular atrophy in mice at P40 (Supplementary Movie 2), due to a hypomyelinating neuropathy with a severe decrease in nerve conduction velocity (Fig. 8a). At P20 and P40, cross sections of sciatic nerves from WT littermates showed numerous myelinated axons. In contrast Prohibitin-2 deficient nerves had few myelinated axons (Fig. 8c–e), with thin myelin sheaths, as documented by an increase in their g-ratio (Fig. 8f,g). A reduction in axonal caliber (Fig. 8h,i) and in compound motor action potentials (Fig. 8b) was also observed. There was no increase in apoptosis (Fig. 8j–l). Notably, large caliber axons that were not myelinated were grouped in immature bundles (Fig. 8c), the hallmark of a defect in axonal sorting44, and a sign of impaired Schwann cell–axonal interactions. These results indicate that Prohibitin-2 is required both for the proper sorting of axons by Schwann cells and for their myelination in vivo.
Here we show that neuronal cell membranes induce the formation of polarized protrusions in glial cells in vitro, mimicking juxtacrine signalling. Using neuronal membranes in the pseudopod fractionation system, we could separate and profile these polarized glial protrusions that interacted with neuronal membranes. Nearly 10% of proteins that we have identified are implicated in glia–axonal interactions and myelination in vivo, validating the system. In addition, neuronal membranes induced the redistribution of a unique and novel set of proteins in Schwann cells. Thus, neuronal membranes can be used as stimuli to study juxtacrine interactions with other neuronal or glial cells. For example, it has been hypothesized that the proteins that we chose to characterize, Prohibitins, function also in neuron–neuron interactions at synapses, and may be dysfunctional in schizophrenia45. More broadly, the concept of isolating the portion of a cell touching another cell can be extended to any system, to study transient juxtacrine interactions, cell–cell junction formation or non-cell autonomous mechanisms in neurodegenerative disorders.
The analysis of the proteome in pseudopods begins to illuminate some of the unique events that are triggered in Schwann cells by neuronal signals. Overall, the interaction with neuronal membranes caused a change of twofold in 16% of the pseudopod proteome (Fig. 3b, Supplementary Data 2). It is possible that this change could have been even more extensive in the presence of a second polarizing cue form Laminins in the basal lamina, which is necessary for proper Schwann cell–axon interactions. The pathway and interactome analysis suggest that, in addition to anticipated roles for signalling related to cytoskeleton and G-protein coupled receptors, local protein translation, sumoylation and metabolic control are crucial at the beginning of myelination.
Cytoskeletal signalling molecules were prominent in pseudopods induced by neuronal membranes. They included regulators of Rho GTPases, Ephrins, axonal guidance molecules and Tec Kinase signalling components, supporting the idea that the cell protrusions extended by myelinating glia has the molecular characteristic of a growth cone or lamellipodia of migrating cells6,46. Subsequent myelin wrapping also requires actin polymerization and depolymerization47,48,49,50. Similarly, G-protein-related signalling was highly represented, supporting an emerging role for G-protein-coupled receptors in myelination29. Of note, many of these molecules were connected in protein–protein interaction networks, which also contained novel proteins, suggesting that the latter may also function in myelination or be involved in inherited human neuropathies.
Our data reveal that local control of protein expression accounts heavily for Schwann cell polarization after axonal contact. Interaction with neuronal membranes modulated the expression of molecules that regulate protein translation and degradation. Also, seven ribosomal proteins, two tRNA ligases, one elongation factor and three proteins associated with mRNA splicing were enriched in pseudopods (together accounting for 14% of the proteins enriched in pseudopods), suggesting either that local RNA regulation and translation is important for the extension of Schwann cells pseudopods or that these proteins serve extraribosomal functions.
In addition, interactome analysis revealed that post-translational modifications, in particular by SUMO, might be important in axo-glial interactions. SUMO-2 was not only redistributed in pseudopods after axonal contact, but is also known to bind or regulate >10 of the other enriched proteins (Fig. 3b), suggesting that sumoylation is an important event in myelination.
Another set of functionally related proteins that was enriched in polarized pseudopods contained enzymes involved in amino-acid metabolism including GOT1, GOT2 and malate dehydrogenase 1 (MDH1), which control levels of aspartate and glutamate, suggesting further mechanisms in neuroprotection1.
We identified the novel family of Prohibitins in pseudopods, and show that they are required for early axo-glial interactions. Indeed, both Prohibitin-1 and -2 are required for myelination in vitro, and deletion of Prohibitin-2 in Schwann cells impairs radial sorting, the process in which Schwann cells segregate large caliber axons that are destined for myelination. Prohibitin-2 may participate locally in the formation of lamellipodia-like polarized protrusions, similar to integrins and cytoskeletal regulators5,6,21, or in the transduction of axonal signals12,51. This latter function could occur in different Schwann cell compartments, because Prohibitins can function in various cellular location, (reviewed in refs 39 and 52) where they interact with specific protein and lipids33,53. In Schwann cells Prohibitin-2 appear to localize at the plasma membrane and mitochondria. The identification of Prohibitin interactors at the plasma membrane will reveal if Prohibitin-2 regulate signalling molecules required for myelination such as GPCR proteins, mTOR, integrins or RhoGTPases.
In T-cells, Prohibitins translocate to the plasma membrane on activation54 and binds to Siglec-9 on other immune cells37. We showed that Prohibitin-2 interacts with Schwann cells membrane proteins, and increased in pseudopods after induction with neuronal membranes, suggesting that axons may induce a redistribution of Prohibitin to pseudopods to promote Schwann cell–axon interactions. Siglecs are immunoglobulin adhesion molecules, like myelin-associated glycoprotein (or Siglec-4), thus it will be important to determine whether axons contain any Siglec molecule on their surface. Finally, Prohibitins are present in oligodendrocytes55 suggesting that they might be important also for central nervous system myelination.
In conclusion, we describe an innovative, modified method to study polarized cellular domains, and we used it for modeling and molecular profiling of the advancing glial sheath and to identify novel molecules involved in the interaction between glial cells and axons. The validation in vivo of one of these novel proteins, Prohibitin-2, demonstrates the validity of the technique for the study of cell–cell interactions.
To induce pseudopods, cells were first starved for 12 h, then trypsinized with 0.5% Trypsin–EDTA, pelleted and resuspended in serum-free medium. Cells (1.5 × 106) were then plated onto the upper compartment of the Boyden chamber insert. We used 4.7 cm2 polycarbonate transwell permeable inserts with 3-μm pores (Corning #3414) coated with 10 μg ml−1 Poly-L-Lysine (Sigma). Cells were maintained in DMEM, 2 mM L-Glutamine and 0.5% bovine serum albumin (BSA) for 4 h at 37 °C to attach and spread on the upper surface of the insert. Next, inserts were washed with PBS and transferred to a six-well plate containing either 200 μl of DMEM alone (no stimulus), or DMEM with either 100 ng ml−1 LPA, or 10 ng ml−1 NRG1 EGF-like domain (sNRG), neuronal or non-neuronal membranes. In other experiments the six-well plates contained MSC, or neurobasal media (Gibco) with rat dorsal root ganglia neurons plated on the bottom of the plate. For some of the experiments requiring induction with neuronal membranes, we modified the Corning six-well plates (Corning #3335) to reduce the distance between the insert and the bottom of the plate to ∼0.2 mm. This reduced the amount of primary neurons required, but did not changed the induction of pseudopods. Pseudopods were allowed to grow for 2 h at 37 °C. To initiate pseudopods retraction, the attractant in the bottom chamber was removed and replaced by serum-free DMEM. For Laminin-111 haptotactic stimulation, the inserts were first coated with Poly-L-Lysine on the top, then they were turned upside down and coated with 10 μg ml−1 of Laminin-111 (Sigma P5899) on the bottom.
Preparation of neuronal membranes
Neuronal membranes were prepared from DRG of rat embryos at 15 gestational days as described in ref. 56. Briefly, 20 DRGs were dissected and plated on 9.5-cm2 dishes in C media: MEM (Gibco), 10% foetal bovine serum, 4 g l−1 D-Glucose, 2 mM L-Glutamine, 50 ng ml−1 Nerve Growth Factor (Harlan). After 12 h cells were switched for 2 weeks in NB medium (Gibco), 1 × B27 supplement (Gibco), 4 g l−1 D-Glucose, 2 mM L-Glutamine, 50 ng ml−1 Nerve Growth Factor (Harlan). To obtain neuron-only cultures, the cells were treated with FUDR (10 μM fluorodeoxyuridine (FdU) and 10 μM uridine) in NB medium for three cycles (2 days with FUDR, 2 days without FUDR). Neurons were collected by scraping the network with forceps and then they were homogenized in PBS with a Dounce homogenizer. The homogenized solution was centrifuged at 300 g for 20 min to remove debris and collagen. The supernatant was centrifuged at 30,000 g for 1 h. The pellets were resuspended in DMEM (67 μl for each 9.5-cm2 dish) and stored at −80 °C for up to 6 months. To test their activity, membranes were centrifuged onto serum starved, rat primary Schwann cells, incubated at 37 °C for an additional 20 min, lysed and analysed by western blotting. CHO and COS-7 membranes were prepared as above using two 10-cm2 dishes of confluent cells as starting material.
Immunofluorescence and immunohistochemistry
For staining and imaging of filter membranes after the induction of pseudopods, Schwann cells on the top chamber and pseudopods on the bottom chamber were sandwiched between two drops of PBS and parafilm, washed twice in PBS and then stained. For phalloidin staining, Schwann cells were fixed with 4% ice-cold paraformaldehyde for 30 min, washed twice with PBS and incubated in quenching solution (75 mM NH4Cl; 20 mM Glycine) for 10 min at room temperature. Cells were then permeabilized with 1.6‰ Saponin in 1% BSA for 15 min at 37 °C and incubated for 1 h at 37 °C with phalloidin-TRITC 1/200 (Sigma, P1951). For immunostaining, Schwann cells were fixed in DOTMAC 0.25%, PFA 4%, washed in PBS, blocked for 1 h in 10% NGS, 3% BSA, 0.1% Triton X-100, 0.05% Tween-20 in 1X PBS and incubated overnight with the following antibodies: BD Pharmingen anti-β1 Integrin 1/100 (553837), Proteintech anti-Phb2 1/100 (12295-1-AP). Filters were then incubated for 1 h with Jackson DyLight 488 1/1,000 or 649-conjugated 1/1,000 secondary antibodies. Filters were next excised from the insert with microscissors and mounted on a slide with Vectashield (Vector Laboratories). Images were acquired with a confocal microscope Leica SP5II. Progressive Z-sections were acquired starting from the upper chamber (above the cell bodies), through the filter membrane, and in the bottom chamber (pseudopod area), and either analysed separately, or stacked in Z-projection that included only one of the compartments (that is, cell body, filter membrane or pseudopod). Three-dimensional reconstructions were performed with Fiji (fiji.sc).
Conventional immunostaining of Schwann cell–neuron co-cultures was performed with the following antibodies: Millipore anti-NFH 1/700 (AB1989) and Covance anti-MBP 1/1000 (SMI-99P) and Jackson DyLight 488 1/1,000 or 549-conjugated 1/1,000 secondary antibodies. Images were acquired with a fluorescent microscope Leica DM6000B. Myelination in vitro was evaluated from four different experiments, performed with two to four coverslips in each case, which is a standard sample size for these experiments. Myelin segments number and length were quantified using Image J software (http://imagej.nih.gov/ij) from two random fields of each culture at the 10 × objective. Data were analysed using Graph pad Prism 6.01. For immunocytochemistry, Schwann cells were fixed in DOTMAC 0.5%, PFA 1%. Coverslips or slide were washed in PBS, blocked for 1 h in 10% NGS, 3% BSA, 0.1% Triton X-100, 0.05% Tween-20 in 1X PBS, then incubated overnight with the following antibodies: Proteintech anti-Phb2 1/100 (12295-1-AP), Covance anti-NFH 1/700 (PCK-593P). For immunohistochemistry, sciatic nerve sections were permeabilized with acetone. Sections were rinsed in PBS, incubated 1 h with Jackson DyLight 488 1/1,000 or 549-conjugated 1/1,000 secondary antibodies, stained with DAPI, and mounted with Vectashield (Vector Laboratories). Images were acquired with a confocal microscope Leica SP5II. Maximum intensity projection was created with Fiji (fiji.sc).
Protein extraction, western blot and antibodies
To extract proteins after the pseudopods assay, Schwann cells plated on filters with pseudopods on the lower side were washed twice in PBS, fixed with ice-cold methanol for 30 min on ice and washed again in PBS. For each filter, either the cell bodies on the upper surface or the pseudopods on the undersurface, were removed with a cotton swab. The remaining pseudopods or cell bodies were scraped into lysis buffer (100 mM Tris pH 7.4, 5 mM EDTA, 150 mM NaCl, 1% SDS, 1 mM sodium orthovanadate, protease inhibitors) and protein quantities were determined using microBCA assay (Thermo Scientific). Proteins were quantified from at least three different experiments. Data were analysed using Graph pad Prism 6.01.
Western blot was performed as described57. To control for equal loading of pseudopod and cell body fractions, blots were stained with Amido Black (Sigma). Blotted membranes were probed overnight with Abcam anti-Histone 2B 1/1,000 (ab1790), anti-ErbB2 1/250 (ab2428), anti-ErbB3 1/250 (ab34641); Cell Signalling anti-Akt 1/1,000 (#9272), anti-p-Akt 1/1,000 (#9271), anti-Fak 1/500 (#3283), anti-p-Fak 1/500 (#3285), anti-Erk 1/1,000 (#9102), anti-p-Erk 1/1,000 (#9101); Millipore anti-Rac1 1/200 (05-389), anti-α5 Integrin 1/250 (ab1928), anti-Prohibitin-2 1/250 (ab10198), anti-Par3 1/500 (07-330); Proteintech anti-Contactin-1 1/200 (13843-1-AP), Sigma anti-Calnexin 1/3,000 (C4731), anti-Tubulin ½,000 (T4026); Novocastra anti-β-Dystroglycan 1/40 (Ncl-b-DG); BD Bioscience anti-N-Cadherin 1/500 (#610920), anti-β1 Integrin 1/100 (#610468); Thermo Scientific anti-Prohibitin-1 1/250 (II-14-10), anti-Pdha1 1/1,000 (gift from Dr Patel, University at Buffalo), anti-Necl4 1/1,000 and anti-Caspr 1/1,000 (gifts from Dr Peles, Weizmann Institute). Membranes were then rinsed in PBS and incubated for 1 h with secondary antibodies. Blots were developed using ECL, ECL plus (GE Healthcare) or the Odyssey CLx infrared imaging system (Li-Cor). Western blots were performed at least two times. Uncropped blot are shown in Supplementary Fig. 7.
How to cite this article: Poitelon, Y. et al. Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination. Nat. Commun. 6:8303 doi: 10.1038/ncomms9303 (2015).
Nave, K. A. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 11, 275–283 (2010).
Cho, S. Y. & Klemke, R. L. Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold. J. Cell Biol. 156, 725–736 (2002).
Mili, S., Moissoglu, K. & Macara, I. G. Genome-wide screen reveals APC-associated RNAs enriched in cell protrusions. Nature 453, 115–119 (2008).
Taveggia, C., Feltri, M. L. & Wrabetz, L. Signals to promote myelin formation and repair. Nat. Rev. Neurol. 6, 276–287 (2010).
Grove, M. et al. FAK is required for axonal sorting by Schwann cells. J. Cell Biol. 176, 277–282 (2007).
Nodari, A. et al. Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination. J. Cell Biol. 177, 1063–1075 (2007).
Goebbels, S. et al. Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J. Neurosci. 30, 8953–8964 (2010).
Newbern, J. M. et al. Specific functions for ERK/MAPK signaling during PNS development. Neuron 69, 91–105 (2011).
Ishii, A., Furusho, M. & Bansal, R. Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J. Neurosci. 33, 175–186 (2013).
Bunge, R. et al. Growth control by cell to cell contact. J. Supramol. Struct. 11, 175–187 (1979).
DeVries, G. H., Salzer, J. L. & Bunge, R. P. Axolemma-enriched fractions isolated from PNS and CNS are mitogenic for cultured Schwann cells. Brain Res. 255, 295–299 (1982).
Taveggia, C. et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47, 681–694 (2005).
Michailov, G. V. et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700–703 (2004).
Syed, N. et al. Soluble neuregulin-1 has bifunctional, concentration-dependent effects on Schwann cell myelination. J. Neurosci. 30, 6122–6131 (2010).
Stassart, R. M. et al. A role for Schwann cell-derived neuregulin-1 in remyelination. Nat. Neurosci. 16, 48–54 (2013).
Lewallen, K. A. et al. Assessing the role of the cadherin/catenin complex at the Schwann cell-axon interface and in the initiation of myelination. J. Neurosci. 31, 3032–3043 (2011).
Wanner, I. B. & Wood, P. M. N-cadherin mediates axon-aligned process growth and cell-cell interaction in rat Schwann cells. J. Neurosci. 22, 4066–4079 (2002).
Spiegel, I. et al. A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nat. Neurosci. 10, 861–869 (2007).
Maurel, P. et al. Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination. J. Cell Biol. 178, 861–874 (2007).
Golan, N. et al. Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy. J. Neurosci. 33, 10950–10961 (2013).
Feltri, M. L. et al. Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 156, 199–209 (2002).
Guo, L., Lee, A. A., Rizvi, T. A., Ratner, N. & Kirschner, L. S. The protein kinase A regulatory subunit R1A (Prkar1a) plays critical roles in peripheral nerve development. J. Neurosci. 33, 17967–17975 (2013).
Seilheimer, B. & Schachner, M. Studies of adhesion molecules mediating interactions between cells of peripheral nervous system indicate a major role for L1 in mediating sensory neuron growth on Schwann cells in culture. J. Cell Biol. 107, 341–351 (1988).
Pasquini, L. A. et al. Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. Cell Death Differ. 18, 1746–1756 (2011).
Yu, T. & Lieberman, A. P. Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin. PLoS Genet. 9, e1003462 (2013).
Benninger, Y. et al. Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J. Cell Biol. 177, 1051–1061 (2007).
Melendez-Vasquez, C. V., Einheber, S. & Salzer, J. L. Rho kinase regulates schwann cell myelination and formation of associated axonal domains. J. Neurosci. 24, 3953–3963 (2004).
Leitman, E. M. et al. MLCK regulates Schwann cell cytoskeletal organization, differentiation and myelination. J. Cell. Sci. 124, 3784–3796 (2011).
Monk, K. R. et al. A G protein-coupled receptor is essential for Schwann cells to initiate myelination. Science 325, 1402–1405 (2009).
Grigoryan, T. et al. Wnt/Rspondin/beta-catenin signals control axonal sorting and lineage progression in Schwann cell development. Proc. Natl Acad. Sci. USA 110, 18174–18179 (2013).
Siconolfi, L. B. & Seeds, N. W. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J. Neurosci. 21, 4348–4355 (2001).
Ikonen, E., Fiedler, K., Parton, R. G. & Simons, K. Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett. 358, 273–277 (1995).
Rajalingam, K. et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell. Biol. 7, 837–843 (2005).
Rahman, H., Qasim, M., Oellerich, M. & Asif, A. R. Identification of the novel interacting partners of the mammalian target of rapamycin complex 1 in human CCRF-CEM and HEK293 cells. Int. J. Mol. Sci. 15, 4823–4836 (2014).
Bavelloni, A. et al. Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. FASEB J. 28, 2009–2019 (2014).
Joshi, B. et al. Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites. Biochem. J. 401, 155–166 (2007).
Yurugi, H. et al. Prohibitins function as endogenous ligands for Siglec-9 and negatively regulate TCR signaling upon ligation. Biochem. Biophys. Res. Commun. 434, 376–381 (2013).
Nuell, M. J. et al. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell Biol. 11, 1372–1381 (1991).
Mishra, S., Ande, S. R. & Nyomba, B. L. The role of prohibitin in cell signaling. FEBS J. 277, 3937–3946 (2010).
Long, L. et al. Dynamic change of Prohibitin2 expression in rat sciatic nerve after crush. Cell Mol. Neurobiol. 33, 689–698 (2013).
Park, S. E. et al. Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo. Mol. Cell Biol. 25, 1989–1999 (2005).
Park, S. et al. Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice. Endocrinology 152, 4336–4349 (2011).
Feltri, M. L. et al. P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann. N. Y. Acad. Sci. 883, 116–123 (1999).
Feltri, M. L., Poitelon, Y. & Previtali, S. C. How schwann cells sort axons: new concepts. Neuroscientist (2015).
Smalla, K. H. et al. A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol. Psychiatry 13, 878–896 (2008).
Sloane, J. A. & Vartanian, T. K. WAVE1 and regulation of actin nucleation in myelination. Neuroscientist 13, 486–491 (2007).
Jin, F. et al. N-WASp is required for Schwann cell cytoskeletal dynamics, normal myelin gene expression and peripheral nerve myelination. Development 138, 1329–1337 (2011).
Novak, N. et al. N-WASP is required for membrane wrapping and myelination by Schwann cells. J. Cell Biol. 192, 243–250 (2011).
Zuchero, J. B. et al. CNS myelin wrapping is driven by actin disassembly. Dev. Cell 34, 152–167 (2015).
Nawaz, S. et al. Actin filament turnover drives leading edge growth during myelin sheath formation in the central nervous system. Dev. Cell 34, 139–151 (2015).
Bermingham, J. R. Jr et al. The claw paw mutation reveals a role for Lgi4 in peripheral nerve development. Nat. Neurosci. 9, 76–84 (2006).
Theiss, A. L. & Sitaraman, S. V. The role and therapeutic potential of prohibitin in disease. Biochim. Biophys. Acta (1813) 1137-43, 2011.
Delage-Mourroux, R. et al. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J. Biol. Chem. 275, 35848–35856 (2000).
Yurugi, H. & Rajalingam, K. A role for prohibitin in mast cell activation: location matters. Sci. Signal. 6, pe29 (2013).
Bernstein, H. G. et al. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromole. Med. 14, 270–280 (2012).
Berti, C. et al. Non-redundant function of dystroglycan and beta1 integrins in radial sorting of axons. Development 138, 4025–4037 (2011).
Pellegatta, M. et al. alpha6beta1 and alpha7beta1 integrins are required in Schwann cells to sort axons. J. Neurosci. 33, 17995–18007 (2013).
We thank R. Klemke (University of California, San Diego) and members of his lab for suggestions with the pseudopod system; E. Peles (Weizmann Institute of Science) and M. Patel (University at Buffalo) for antibodies. This work was funded by grants NIH R01 NS045630 and 5R21HD075363 (to M.L.F.), NS055256 (to L.W.).
The authors declare no competing financial interests.
Supplementary Figures 1-7, Supplementary Methods and Supplementary References (PDF 1264 kb)
SILAC mass spectrometry data from Schwann cell bodies and pseudopods induced by neuronal membranes. List of proteins identified by two independent SILAC proteomic analyses in Schwann cell pseudopods or cell bodies, after induction by neuronal membranes, as compared to the proteins present in both compartments without stimulus (DMEM only). For SILAC ratio, protein intensities were normalized by the total protein intensities of the cell body or of the pseudopod proteome. (XLSX 282 kb)
Proteins more abundant in pseudopods and enriched by neuronal membranes. 95 proteins were found to be more abundant in pseudopods (Ps/CB ratio > 1.25) after induction by neuronal membranes (Ps induced/non-induced > 1). The subcellular localization of each protein was derived from UniProt subcellular location. (XLSX 45 kb)
Label-free mass spectrometry data from Schwann cell bodies and pseudopods, after induction with serum and growth factors. List of proteins identified by two different label-free proteomic analyses in Schwann cell body and pseudopod, after induction by fetal calf serum and growth factors. (XLSX 125 kb)
SILAC mass spectrometry from neuronal membranes and comparison with Schwann cell pseudopods induced by neuronal membranes. List of proteins identified by SILAC proteomic analysis in neuronal membranes. (XLSX 140 kb)
Protein ontology analysis from proteins identified in Schwann cell pseudopods. Complete protein ontology analysis of the significant canonical pathways in Schwann cell pseudopods. 162 pathways are increased after neuronal membrane stimulation as compared to DMEM. (XLSX 37 kb)
Literature supporting the protein-protein interaction predictions. References supporting the protein-protein interaction network shown in Figure 3B. (XLSX 44 kb)
Z-stack from Schwann cells extending pseudopods toward axonal membranes. Reconstruction through the z-axis of Schwann cells extending pseudopods through 3 μm pores of a microporous Boyden chamber filter in response to neuronal membranes. Note the thickness of the filter around 5-6 μm. Schwann cells were exposed to neuronal membranes for 2 h, fixed then stained with TRITC-phalloidin and DAPI. (MOV 5124 kb)
Phenotypic observation of mice after Phb2 ablation in Schwann cells. 40 days old Phb2 f/f; P0-Cre and Phb2 f/f mice. The mutant animal (always in the field of view) is smaller than the wild type littermate (entering the field of view on the right), and presents paralysis of one hind limb with gait impairment, tremor and muscle atrophy, all signs of a severe peripheral neuropathy. (MOV 4066 kb)
About this article
Cite this article
Poitelon, Y., Bogni, S., Matafora, V. et al. Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination. Nat Commun 6, 8303 (2015). https://doi.org/10.1038/ncomms9303
This article is cited by
Nature Communications (2021)
Nature Neuroscience (2020)
Proteomic profiling of human cancer pseudopodia for the identification of anti-metastatic drug candidates
Scientific Reports (2018)
Nature Communications (2017)